DYSTROPHIN-DEFICIENT MYOFIBERS ARE VULNERABLE TO MAST-CELL GRANULE-INDUCED NECROSIS

被引:59
作者
GOROSPE, JRM
THARP, M
DEMITSU, T
HOFFMAN, EP
机构
[1] UNIV PITTSBURGH, SCH MED, DEPT MOLEC GENET & BIOCHEM, PITTSBURGH, PA 15261 USA
[2] UNIV PITTSBURGH, SCH MED, DEPT HUMAN GENET, PITTSBURGH, PA 15261 USA
[3] UNIV PITTSBURGH, SCH MED, DEPT PEDIAT, PITTSBURGH, PA 15261 USA
[4] UNIV PITTSBURGH, SCH MED, DEPT DERMATOL, PITTSBURGH, PA 15261 USA
关键词
DYSTROPHIN; MDX; MAST CELLS; DUCHENNE DYSTROPHY;
D O I
10.1016/0960-8966(94)90068-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Duchenne muscular dystrophy is the most common inherited lethal X-linked disorder of mankind and is caused by dystrophin deficiency. The steps involved in the dystrophin-deficiency-induced cascade which lead to myofiber necrosis, progressive muscle wasting in humans and dogs and prominent muscle hypertrophy in mice and cats are obscure. Dystrophin is an intracellular component of the membrane cytoskeleton and its absence would be expected to cause necrosis of isolated myofibers (cell autonomous defect). However, all dystrophin-deficient muscles characteristically show simultaneous degeneration of large groups of muscle fibers (grouped necrosis). This implies that cell death may be mediated by extracellular, non-cell autonomous factors which occur as a secondary consequence of dystrophin deficiency. We have proposed a model where tissue pathology may be mediated by infiltrating mast cells (Gorospe et al., J Neurol Sci 1994). Here we show that intramuscular injections of purified mast cell granules induce widespread myofiber necrosis in dystrophin-deficient mdx mice, but not in normal mice. These data support the hypothesis that dystrophin acts as a plasma membrane stabilizer and that its deficiency renders myofibers more susceptible to damage from mast cell proteases. Moreover, our results support the hypothesis that mast cell degranulation may be a trigger for myofiber death in dystrophin-deficient muscle.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 33 条
  • [1] BASIC FIBROBLAST GROWTH-FACTOR BINDS TO SUBENDOTHELIAL EXTRACELLULAR-MATRIX AND IS RELEASED BY HEPARITINASE AND HEPARIN-LIKE MOLECULES
    BASHKIN, P
    DOCTROW, S
    KLAGSBRUN, M
    SVAHN, CM
    FOLKMAN, J
    VLODAVSKY, I
    [J]. BIOCHEMISTRY, 1989, 28 (04) : 1737 - 1743
  • [2] THE MDX MOUSE SKELETAL-MUSCLE MYOPATHY .1. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION
    COULTON, GR
    MORGAN, JE
    PARTRIDGE, TA
    SLOPER, JC
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1988, 14 (01) : 53 - 70
  • [3] MODES OF FGF RELEASE INVIVO AND INVITRO
    DAMORE, PA
    [J]. CANCER AND METASTASIS REVIEWS, 1990, 9 (03) : 227 - 238
  • [4] ELEVATED BASIC FIBROBLAST GROWTH-FACTOR IN THE SERUM OF PATIENTS WITH DUCHENNE MUSCULAR-DYSTROPHY
    DAMORE, PA
    BROWN, RH
    KU, PT
    HOFFMAN, EP
    WATANABE, H
    ARAHATA, K
    ISHIHARA, T
    FOLKMAN, J
    [J]. ANNALS OF NEUROLOGY, 1994, 35 (03) : 362 - 365
  • [5] VARIABLE CLINICAL SEVERITY OF HEREDITARY SPHEROCYTOSIS - RELATION TO ERYTHROCYTIC SPECTRIN CONCENTRATION, OSMOTIC FRAGILITY, AND AUTOHEMOLYSIS
    EBER, SW
    ARMBRUST, R
    SCHROTER, W
    [J]. JOURNAL OF PEDIATRICS, 1990, 117 (03) : 409 - 416
  • [6] ENGEL AG, 1986, MYOLOGY, P1185
  • [7] Engel W.K., 1977, PATHOGENESIS HUMAN M, P277
  • [8] DEFICIENCY OF A GLYCOPROTEIN COMPONENT OF THE DYSTROPHIN COMPLEX IN DYSTROPHIC MUSCLE
    ERVASTI, JM
    OHLENDIECK, K
    KAHL, SD
    GAVER, MG
    CAMPBELL, KP
    [J]. NATURE, 1990, 345 (6273) : 315 - 319
  • [9] GOLDSTEIN SM, 1993, MAST CELL HLTH DIS, P343
  • [10] Gorospe Jose Rafael M., 1992, Current Opinion in Rheumatology, V4, P794